Healthcare Bioconvergence Business Analysis Report 2026: An $187.9 Billion Market by 2032 – Lab-on-a-Chip and Organ-on-Chip Technologies Drive Disruptive Innovation

GlobeNewswire

Image Credit: GlobeNewswire

Please find more details at GlobeNewswire

Summary

The healthcare bioconvergence market is poised for growth driven by the integration of biology, engineering, and AI, promoting breakthroughs in personalized medicine, regenerative therapies, and biofabrication. Innovations in AI-powered diagnostics, bioelectr

Source: GlobeNewswire

Read More

(0)

Exclusive AI-Powered News Insights (For Members only)

Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!